Encyclopedia

  • Determination of a new calcium antagonist, sesamodil (cas 116476-14-3) fumarate (SD-3211), and its metabolite in plasma by liquid chromatography with electrochemical detection
  • Add time:08/13/2019         Source:sciencedirect.com

    A sensitive and selective high-performance liquid chromatographic method is described for the determination of a novel calcium antagonist, (+)-(R)-3,4-dihydro-2-[5-methoxy-2-[3-[N-methyl-N-[2-[(3,4-methylenedioxy)phenoxy]ethyl]amino]propoxy]phenyl]-4-methyl-3-oxo-2H-1,4-benzothiazine hydrogen fumarate (sesamodil (cas 116476-14-3) fumarate; JAN, SD-3211, I), and its N-desmethylated metabolite (II) in plasma. Compounds I and II and an internal standard were isolated from plasma by solid-phase and liquid-liquid extraction. The extract was chromatographed on a reversed-phase C18 column, and the compounds of interest were detected by dual coulometric electrodes operated in an oxidative screen mode. The limit of determination for both I and II was at least 0.4 ng/ml in plasma. The utility of the assay was demonstrated by determining plasma levels of I and II in five dogs administered an oral dose of 60 mg of the drug.

    We also recommend Trading Suppliers and Manufacturers of sesamodil (cas 116476-14-3). Pls Click Website Link as below: cas 116476-14-3 suppliers


    Prev:Regular ArticleSEMOTIADIL (cas 116476-13-2), a new calcium antagonist, is a very potent inhibitor of LDL-oxidation
    Next: Regular ArticleBinding Study of Semotiadil and Levosemotiadil (cas 116476-16-5) with α1-Acid Glycoprotein Using High-Performance Frontal Analysis)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View